Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Experimental group:Post-marketing vaccination of COVID-19 vaccine
Sponsors
Shenzhen Futian Hospital for Rheumatic Diseases
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.The subjects were Chinese adults diagnosed with rheumatism; 2.Aged 18 to 60 years; 3.Patients know their diagnosis clearly; 4.Have basic reading and comprehension skills; 5.Cognitive ability, mental disorders, etc.
Exclusion criteria
Exclusion criteria: Researchers believe that other reasons are not suitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Novel Coronavirus neutralizing antibody; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions; | — |
Countries
China
Contacts
Public ContactZeng Huiqiong
Shenzhen Futian Hospital for Rheumatic Diseases
Outcome results
None listed